Balance Sheet MedinCell S.A.

Equities

MEDCL

FR0004065605

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:35:06 2025-01-17 am EST			5-day change	1st Jan Change
16.30 ^EUR	+0.37%		-1.09%	-1.93%

Dec. 13	Eutelsat: delisted from the SBF 120 and CAC Mid 60 indices	CF
Dec. 13	Euroapi: delisted from the SBF 120 and CAC Mid 60 indices	CF

e73e4d3980f062a5f578ea2442b8db6.vtmLUh92FXrYonHRRvR3xAliXjroyuB3m3qqAvjauYc.xK_5HHkdLTGd5DakfqQk_XowGwOZgbVP0yPTcYiFyfeJscohUyBjM7nyPA

Published financial data: MEDINCELL S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	2.85M	8.19M	4.09M	9.89M	9.03M
Other Revenues, Total	3.15M	3.59M	1K	3.77M	2.91M
Total Revenues	6M	11.78M	4.09M	13.66M	11.94M
Cost of Goods Sold, Total	-	-	-	-	-
Gross Profit	6M	11.78M	4.09M	13.66M	11.94M
Selling General & Admin Expenses, Total	7.96M	7.58M	8.49M	9.72M	11.79M
R&D Expenses	17.21M	19.56M	23.58M	27.92M	21.05M
Other Operating Expenses	7K	5K	81K	44K	40K
Other Operating Expenses, Total	25.18M	27.14M	32.15M	37.68M	32.88M
Operating Income	-19.18M	-15.37M	-28.06M	-24.02M	-20.94M
Interest Expense, Total	-2.11M	-3.58M	-1.84M	-3.93M	-4.62M
Interest And Investment Income	64K	40K	46K	41K	553K
Net Interest Expenses	-2.05M	-3.54M	-1.8M	-3.89M	-4.06M
Currency Exchange Gains (Loss)	76K	-226K	829K	1.17M	135K
Other Non Operating Income (Expenses)	-144K	356K	-23K	-5.2M	-44K
EBT, Excl. Unusual Items	-21.29M	-18.78M	-29.05M	-31.95M	-24.91M
Gain (Loss) On Sale Of Investments	-	-	-	-37K	-
Gain (Loss) On Sale Of Assets	-	-	3K	-	-
Asset Writedown	-50K	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-100K	-239K	4.24M	-21K	-37K
EBT, Incl. Unusual Items	-21.44M	-19.02M	-24.81M	-32.01M	-24.95M
Income Tax Expense	2.47M	-	-	-	88K
Earnings From Continuing Operations	-23.92M	-19.02M	-24.81M	-32.01M	-25.04M
Net Income to Company	-23.92M	-19.02M	-24.81M	-32.01M	-25.04M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-23.92M	-19.02M	-24.81M	-32.01M	-25.04M
Net Income to Common Incl Extra Items	-23.92M	-19.02M	-24.81M	-32.01M	-25.04M
Net Income to Common Excl. Extra Items	-23.92M	-19.02M	-24.81M	-32.01M	-25.04M
Per Share Items
Net EPS - Basic	-1.19	-0.86	-1	-1.27	-0.88
Basic EPS - Continuing Operations	-1.19	-0.86	-1	-1.27	-0.88
Basic Weighted Average Shares Outstanding	20.11M	22.04M	24.84M	25.15M	28.42M
Net EPS - Diluted	-1.19	-0.86	-1	-1.27	-0.88
Diluted EPS - Continuing Operations	-1.19	-0.86	-1	-1.27	-0.88
Diluted Weighted Average Shares Outstanding	20.11M	22.04M	24.84M	25.15M	28.42M
Normalized Basic EPS	-0.66	-0.53	-0.73	-0.79	-0.55
Normalized Diluted EPS	-0.66	-0.53	-0.73	-0.79	-0.55
Supplemental Items
EBITDA	-18.36M	-14.56M	-27.2M	-23.05M	-20.05M
EBITA	-19.18M	-15.37M	-28.06M	-24.02M	-20.94M
EBIT	-19.18M	-15.37M	-28.06M	-24.02M	-20.94M
EBITDAR	-18.02M	-	-	-22.33M	-19.98M
Total Revenues (As Reported)	6M	11.78M	8.34M	13.66M	11.94M
Effective Tax Rate - (Ratio)	-11.53	-	-	-	-0.35
Total Current Taxes	-	-	-	-	88K
Total Deferred Taxes	2.47M	-	-	-	-
Normalized Net Income	-13.31M	-11.74M	-18.16M	-19.97M	-15.57M
Interest on Long-Term Debt	1.1M	800K	100K	35K	4.51M
Non-Cash Pension Expense	-24K	-23K	-11K	-5K	5K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	-	-	-	-	2.31M
Selling and Marketing Expenses	2.36M	1.8M	2.27M	2.59M	2.64M
General and Administrative Expenses	5.6M	5.78M	6.21M	7.13M	9.15M
Research And Development Expense From Footnotes	17.26M	19.61M	23.61M	27.92M	21.08M
Net Rental Expense, Total	349K	-	-	720K	65K
Imputed Operating Lease Interest Expense	194K	-	-	431K	39.22K
Imputed Operating Lease Depreciation	155K	-	-	289K	25.78K
Stock-Based Comp., R&D Exp. (Total)	1.16M	1.12M	1.59M	1.41M	1.72M
Stock-Based Comp., S&M Exp. (Total)	143K	125K	322K	268K	332K
Stock-Based Comp., G&A Exp. (Total)	353K	318K	485K	601K	760K
Total Stock-Based Compensation	1.66M	1.56M	2.39M	2.28M	2.81M

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	12.38M	47.1M	24.62M	6.47M	19.46M
Short Term Investments	12K	2.79M	1.97M	3K	-
Total Cash And Short Term Investments	12.39M	49.88M	26.59M	6.47M	19.46M
Accounts Receivable, Total	620K	883K	799K	2.09M	2.25M
Other Receivables	3.76M	3.71M	4.88M	10.18M	4.46M
Total Receivables	4.38M	4.59M	5.68M	12.27M	6.71M
Inventory	-	-	-	-	-
Prepaid Expenses	590K	865K	1.14M	744K	966K
Other Current Assets, Total	375K	986K	665K	82K	118K
Total Current Assets	17.73M	56.32M	34.07M	19.57M	27.26M
Gross Property Plant And Equipment	6.54M	6.91M	10.87M	11M	10.83M
Accumulated Depreciation	-2.48M	-3.06M	-3.84M	-4.63M	-5.4M
Net Property Plant And Equipment	4.05M	3.85M	7.03M	6.37M	5.43M
Long-term Investments	587K	1.08M	1.27M	902K	1.27M
Other Intangibles, Total	1.51M	1.49M	1.67M	1.92M	2.45M
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	3.42M	859K	259K	572K	536K
Total Assets	27.31M	63.61M	44.3M	29.34M	36.95M
Liabilities
Accounts Payable, Total	3.14M	2.96M	2.98M	4.18M	1.85M
Accrued Expenses, Total	1.05M	1.96M	1.42M	2.48M	3.15M
Current Portion of Long-Term Debt	1.46M	3.18M	27.76M	42.81M	5.52M
Current Portion of Leases	323K	390K	581K	643K	643K
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	404K	4.85M	5.29M	5.78M	5.18M
Other Current Liabilities	232K	265K	210K	1.13M	129K
Total Current Liabilities	6.6M	13.6M	38.24M	57.02M	16.47M
Long-Term Debt	31.28M	39.07M	16.25M	11.71M	56.29M
Long-Term Leases	779K	705K	2.9M	2.54M	2.26M
Unearned Revenue Non Current	4.2M	840K	-	-	-
Pension & Other Post Retirement Benefits	398K	451K	265K	354K	365K
Other Non Current Liabilities	-	23K	22K	2K	2.4M
Total Liabilities	43.26M	54.69M	57.67M	71.63M	77.77M
Common Stock, Total	201K	247K	251K	253K	291K
Additional Paid In Capital	33.19M	75.15M	6.91M	7.42M	31.01M
Retained Earnings	-23.92M	-19.02M	-24.81M	-32.01M	-25.04M
Comprehensive Income and Other	-25.43M	-47.46M	4.27M	-17.95M	-47.09M
Total Common Equity	-15.96M	8.92M	-13.37M	-42.29M	-40.82M
Minority Interest	-	-	-	-	-
Total Equity	-15.96M	8.92M	-13.37M	-42.29M	-40.82M
Total Liabilities And Equity	27.31M	63.61M	44.3M	29.34M	36.95M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.11M	24.68M	25.11M	28.71M	29.09M
ECS Total Common Shares Outstanding	20.11M	24.68M	25.11M	25.28M	29.07M
Book Value / Share	-0.79	0.36	-0.53	-1.67	-1.4
Tangible Book Value	-17.46M	7.43M	-15.04M	-44.22M	-43.27M
Tangible Book Value Per Share	-0.87	0.3	-0.6	-1.75	-1.49
Total Debt	33.84M	43.34M	47.49M	57.71M	64.71M
Net Debt	21.45M	-6.54M	20.9M	51.24M	45.25M
Debt Equivalent of Unfunded Proj. Benefit Obligation	398K	451K	265K	354K	365K
Debt Equivalent Oper. Leases	2.79M	-	-	5.76M	520K
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	13K	13K	14K	15K	15K
Account Code - Inventory Valuation	5	5	5	5	5
Machinery, Total	5.07M	5.69M	7.14M	7.36M	7.64M
Full Time Employees	133	138	139	131	134
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	-23.92M	-19.02M	-24.81M	-32.01M	-25.04M
Depreciation & Amortization - CF	1.04M	1.14M	1.36M	1.5M	1.52M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	1.04M	1.14M	1.36M	1.5M	1.52M
Amortization of Deferred Charges, Total - (CF)	221K	196K	161K	166K	197K
(Gain) Loss From Sale Of Asset	36K	-	-3K	33K	296K
Stock-Based Compensation (CF)	1.66M	1.56M	2.39M	2.28M	2.81M
Other Operating Activities, Total	4.86M	3.36M	1.9M	10.06M	5.11M
Change In Accounts Receivable	-237K	-264K	84K	-1.29M	-161K
Change In Inventories	-	-	-	-	-
Change In Accounts Payable	1.48M	-180K	26K	1.2M	-2.33M
Change in Other Net Operating Assets	2.32M	1.07M	-2.48M	-2.94M	5.67M
Cash from Operations	-12.54M	-12.14M	-21.36M	-21M	-11.92M
Capital Expenditure	-575K	-645K	-1.62M	-576K	-324K
Sale of Property, Plant, and Equipment	-	-	16K	48K	1K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-314K	-174K	-351K	-451K	-867K
Investment in Marketable and Equity Securities, Total	918K	-284K	1.55M	2.23M	24K
Other Investing Activities, Total	43K	41K	95K	44K	553K
Cash from Investing	72K	-1.06M	-316K	1.3M	-613K
Long-Term Debt Issued, Total	8.4M	18.71M	3.31M	29.98M	13.84M
Total Debt Issued	8.4M	18.71M	3.31M	29.98M	13.84M
Long-Term Debt Repaid, Total	-3.3M	-9.57M	-2.84M	-24.77M	-9.46M
Total Debt Repaid	-3.3M	-9.57M	-2.84M	-24.77M	-9.46M
Issuance of Common Stock	28K	42.28M	48K	810K	23.32M
Repurchase of Common Stock	-43K	-	-192K	-	-25K
Other Financing Activities, Total	-1.52M	-3.5M	-1.13M	-4.46M	-2.15M
Cash from Financing	3.56M	47.92M	-800K	1.56M	25.53M
Miscellaneous Cash Flow Adjustments	-3K	-	-	1K	-
Net Change in Cash	-8.91M	34.72M	-22.48M	-18.15M	12.99M
Supplemental Items
Cash Interest Paid	1.53M	3.5M	1.13M	4.46M	2.15M
Levered Free Cash Flow	-11.48M	-5.65M	-17.93M	-16.5M	-10.6M
Unlevered Free Cash Flow	-10.16M	-3.41M	-16.78M	-14.04M	-7.72M
Change In Net Working Capital	203K	-4.11M	1.18M	1.94M	-2.04M
Net Debt Issued / Repaid	5.1M	9.14M	470K	5.21M	4.38M

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	-36.71	-21.13	-32.5	-40.78	-39.49
Return on Total Capital	-46.85	-27.39	-40.5	-60.63	-66.61
Return On Equity %	492.33	540.19	1.17K	115.01	60.25
Return on Common Equity	492.33	540.19	1.17K	115.01	60.25
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	132.68	64.33	207.43	71.15	98.72
EBITDA Margin %	-306.08	-123.69	-664.78	-168.81	-167.82
EBITA Margin %	-319.58	-130.51	-685.87	-175.94	-175.3
EBIT Margin %	-319.58	-130.51	-685.87	-175.94	-175.3
Income From Continuing Operations Margin %	-398.58	-161.53	-606.36	-234.42	-209.61
Net Income Margin %	-398.58	-161.53	-606.36	-234.42	-209.61
Net Avail. For Common Margin %	-398.58	-161.53	-606.36	-234.42	-209.61
Normalized Net Income Margin	-221.79	-99.69	-443.82	-146.25	-130.35
Levered Free Cash Flow Margin	-191.35	-47.99	-438.24	-120.81	-88.75
Unlevered Free Cash Flow Margin	-169.34	-28.98	-410.07	-102.82	-64.59
Asset Turnover
Asset Turnover	0.18	0.26	0.08	0.37	0.36
Fixed Assets Turnover	1.63	2.98	0.75	2.04	2.02
Receivables Turnover (Average Receivables)	5.69	10.89	4.86	6.84	4.16
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	2.69	4.14	0.89	0.34	1.66
Quick Ratio	2.54	4.01	0.84	0.33	1.59
Operating Cash Flow to Current Liabilities	-1.9	-0.89	-0.56	-0.37	-0.72
Days Sales Outstanding (Average Receivables)	64.36	33.51	75.05	53.37	88.08
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-	-	-	-	-
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	-212.04	486.15	-355.18	-136.44	-158.5
Total Debt / Total Capital	189.25	82.94	139.19	374.4	270.94
LT Debt/Equity	-200.9	446.12	-143.19	-33.7	-143.41
Long-Term Debt / Total Capital	179.31	76.11	56.11	92.47	245.14
Total Liabilities / Total Assets	158.44	85.98	130.18	244.16	210.49
EBIT / Interest Expense	-9.07	-4.29	-15.22	-6.11	-4.54
EBITDA / Interest Expense	-8.58	-3.97	-14.48	-5.73	-4.21
(EBITDA - Capex) / Interest Expense	-8.86	-4.15	-15.36	-5.88	-4.28
Total Debt / EBITDA	-1.87	-3.05	-1.78	-2.56	-3.33
Net Debt / EBITDA	-1.18	0.46	-0.78	-2.27	-2.33
Total Debt / (EBITDA - Capex)	-1.81	-2.91	-1.68	-2.5	-3.28
Net Debt / (EBITDA - Capex)	-1.15	0.44	-0.74	-2.22	-2.29
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	48.26	96.25	-50.02	63.77	-12.52
Gross Profit, 1 Yr. Growth %	51.21	96.25	-50.02	63.77	-12.52
EBITDA, 1 Yr. Growth %	23.15	-20.69	50.06	0.44	-13.04
EBITA, 1 Yr. Growth %	23.65	-19.85	48.25	0.89	-12.84
EBIT, 1 Yr. Growth %	23.65	-19.85	48.25	0.89	-12.84
Earnings From Cont. Operations, 1 Yr. Growth %	21.51	-20.47	30.65	29.04	-21.78
Net Income, 1 Yr. Growth %	21.48	-20.47	30.65	29.04	-21.78
Normalized Net Income, 1 Yr. Growth %	11.2	-11.79	30.06	28.82	-22.03
Diluted EPS Before Extra, 1 Yr. Growth %	4.32	-27.5	16.01	27.27	-30.67
Accounts Receivable, 1 Yr. Growth %	61.88	42.42	-9.51	161.95	7.69
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	22.18	-4.96	82.48	-9.37	-14.74
Total Assets, 1 Yr. Growth %	-28.11	132.93	-30.35	-33.78	25.93
Tangible Book Value, 1 Yr. Growth %	-464.08	-142.54	-296.79	194.07	-2.14
Common Equity, 1 Yr. Growth %	-355.61	-155.87	-246.5	216.31	-3.48
Cash From Operations, 1 Yr. Growth %	-21.3	-3.21	76.05	-1.67	-43.24
Capital Expenditures, 1 Yr. Growth %